Quantitative Analysis of the Microtubule Interaction of Rabies Virus P3 Protein: Roles in Immune Evasion and

Aaron Brice1, Donna R Whelan2, Naoto Ito3,4

  • 1Viral Pathogenesis Laboratory, Department of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Scientific Reports
|September 22, 2016
PubMed

Insights

Rabies virus (RABV) P3 protein interactions with microtubules are crucial for pathogenicity. A single mutation impairs microtubule binding, reducing viral disease potential and interferon antagonism.

Area of Science:

  • Virology and Cell Biology
  • Microbiology and Infectious Diseases

Background:

  • Microtubules (MTs) are vital for intracellular transport, and viruses often hijack them.
  • Viral proteins can manipulate MTs to subvert cellular processes, but their role in pathogenesis is unclear.
  • The rabies virus (RABV) P3 protein is a potential MT-associated protein (MAP) involved in viral pathogenesis.

Purpose of the Study:

  • To investigate the role of the RABV P3 protein's interaction with microtubules in viral pathogenesis.
  • To determine if specific P3 protein-microtubule interactions are essential for disease development.

Main Methods:

  • Quantitative comparison of P3 protein phenotypes from pathogenic (Nishigahara) and non-pathogenic (Ni-CE) RABV strains.
  • Confocal/live-cell imaging and super-resolution microscopy (dSTORM) to analyze protein-MT interactions.
  • Assessment of STAT1 association with MTs and interferon (IFN)/STAT1-dependent antiviral signaling.

Main Results:

  • The P3 protein from the non-pathogenic Ni-CE strain showed significantly impaired interaction with MTs compared to the pathogenic strain.
  • This impaired MT interaction correlated with a reduced ability to associate STAT1 with MTs and antagonize IFN/STAT1 signaling.
  • A single mutation in Ni-CE-P3 was identified that inhibits MT-association and IFN-antagonist function, and this mutation alone attenuated RABV pathogenicity.

Conclusions:

  • The interaction between viral proteins, specifically RABV P3, and microtubules is critical for viral pathogenesis.
  • The viral protein-MT interface represents a potential target for developing novel antiviral therapies and vaccines.
  • Understanding these molecular interactions can elucidate mechanisms of viral disease and host immune evasion.